Alelsandra Jakubiak

The company's mission is to holistically address all unmet needs from the medical and biotechnology sectors. We offer an interdisciplinary and comprehensive approach to a given issue, development of a strategy and operational support in its implementation until satisfactory results are achieved. The company provides services in the areas of strategic marketing and operational marketing, sales, R&D, medical affairs & profED, market access & governmental affairs, regulatory affairs, compliance. We point out the medically, economically and logistically optimal path. We support: B2B – from need to commercialisation of innovative solutions ➔ strategic and tactical consulting, business/portfolio development, including the creation of measurable business models ➔ sales support and tactical activities (including the development of campaigns and medical materials) ➔ segmentation and targeting; creation of a database of potential customers ➔ research and development and support in (bio)technological processes ➔ support in market access, regulatory and compliance activities ➔ implementation of ISO, GMP, GCP and other quality systems; obtaining accreditation ➔ representing the company at scientific and commercial events ➔ negotiating business terms with customers ➔ employee training, etc. B2PublicSector – highest quality services with cost optimisation ➔ strategic consulting for institutions (consulting for decision-makers) ➔ support in the development of the service portfolio, introduction of a new organisational structure, modernisation of medical facilities ➔ increasing access to advanced technologies and developing a tender strategy ➔ consulting and support in staff development, exchange of experiences and establishing cooperation with foreign institutions ➔ organisation of mobile AOS/POZ ➔ for medical professionals: assistance in preparing sessions/publications for scientific events; competence development B2Science – transfer of science to business ➔ identification and creation of business partnerships for cooperation with entities from the MedTech, BioTech and Pharma sectors ➔ creation of scalable business models and assessment of investment potential ➔ consulting on clinical trial issues ➔ organisation of cooperation with foreign entities ➔ integration of communities (including business and science) B2C (here: Patient) – equal opportunities (in access to healthcare) ➔ individual consulting on medical sector services ➔ increasing the efficiency of the patient pathway, accessibility and quality of healthcare services ➔ integration of the needs of patients and professionals; services provided in several languages at EU level and beyond